Tag: bisphosphonates

1. In this target trial emulation study, denosumab was associated with an increased risk of major adverse cardiovascular events compared ...

1. In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as ...

1. Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab use are associated with reduced clinical fractures in postmenopausal patients with osteoporosis. 2. ...

1. Bisphosphonates and denosumab increased bone mineral density (BMD) in men receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer, ...

1. In a prospective cohort study of over 89 000 postmenopausal women, the use of bisphosphonates for osteoporosis was associated ...

1. A single dose of zoledronic acid improved bone mineral density over 2 years in frail elderly women. 2. Rates ...

1. This systematic review demonstrated that in postmenopausal women with osteoporosis, bisphosphonates, denosumab and teriparatide were associated with a significantly ...